Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim

BACKGROUND: The legalization of hemp in the USA has led to tremendous growth in the availability of hemp-derived products, particularly cannabidiol (CBD) products. The lack of regulatory oversight in this industry has resulted in the marketing and sale of CBD products with questionable ingredients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Erin, Kilgore, Michael, Babalonis, Shanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169299/
https://www.ncbi.nlm.nih.gov/pubmed/35658956
http://dx.doi.org/10.1186/s42238-022-00140-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169299/
https://www.ncbi.nlm.nih.gov/pubmed/35658956
http://dx.doi.org/10.1186/s42238-022-00140-1

Ejemplares similares